ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wisconsin » Neurology

Top Neurology Prescribers in Wisconsin

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
THOMAS MATTIO MD

Neurology

2,466

$623K

217
148 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$252
Average prescription price

Avg: $206

ELENA KORNIYCHUK M.D.

Neurology

2,453

$267K

210
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 22%

$109
Average prescription price

Avg: $206

JAVAID IQBAL M.D.

Neurology

2,450

$540K

278
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$220
Average prescription price

Avg: $206

SAKSHI BAJAJ MD

Neurology

2,432

$458K

343
286 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 22%

$188
Average prescription price

Avg: $206

SUSAN HIBBS MD

Neurology

2,428

$1.02M

234
127 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 22%

$418
Average prescription price

Avg: $206

MARY GOODSETT MD

Neurology

2,382

$1.17M

240
134 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 22%

$489
Average prescription price

Avg: $206

LISA KOKONTIS MD

Neurology

2,343

$364K

195
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$155
Average prescription price

Avg: $206

AURELIA KOZIEL-ANDRZEJEWSKA

Neurology

2,309

$718K

146
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 22%

$311
Average prescription price

Avg: $206

THULASIRAMAN RAVICHANDRAN MD

Neurology

2,244

$320K

226
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 22%

$143
Average prescription price

Avg: $206

ROLAND MORE MD

Neurology

2,212

$461K

238
109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 22%

$209
Average prescription price

Avg: $206

AMIT BISWAS MD

Neurology

2,171

$311K

269
164 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 22%

$143
Average prescription price

Avg: $206

MARCO DOTTI MD

Neurology

2,164

$599K

285
190 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$277
Average prescription price

Avg: $206

STEVEN PRICE MD

Neurology

2,122

$548K

179
106 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$258
Average prescription price

Avg: $206

TODD RAVE MD

Neurology

2,103

$416K

236
125 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$198
Average prescription price

Avg: $206

TERESA MANGIN MD

Neurology

2,079

$450K

260
210 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$216
Average prescription price

Avg: $206

MICHAEL FRUCHT MD

Neurology

2,077

$339K

232
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 22%

$163
Average prescription price

Avg: $206

LAWRENCE SULLIVAN

Neurology

2,073

$438K

255
211 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 22%

$211
Average prescription price

Avg: $206

VERONICA SOSA MD

Neurology

2,022

$338K

137
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 22%

$167
Average prescription price

Avg: $206

DAVID NYE MD

Neurology

1,964

$90.3K

242
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

9%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $206

MARIE TOMASI M.D.

Neurology

1,944

$158K

201
115 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 22%

$81
Average prescription price

Avg: $206

JOSHUA MORRISON MD

Neurology

1,868

$454K

208
126 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$243
Average prescription price

Avg: $206

BRADLEY HINER MD

Neurology

1,742

$194K

204
143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 22%

$111
Average prescription price

Avg: $206

MICHAEL LEVIN M.D.

Neurology

1,726

$242K

201
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 22%

$140
Average prescription price

Avg: $206

SHARAT AHLUWALIA MD

Neurology

1,720

$418K

181
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 22%

$243
Average prescription price

Avg: $206

ROSE DOTSON MD

Neurology

1,714

$345K

174
120 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 22%

$201
Average prescription price

Avg: $206

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank